ClinicalTrials.govpublic full text
A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness
participants less than 12 months of age with rsv illness, respiratory syncytial viruses, rsv, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805555
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.